Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 4465 to 4471 of 4471 entries
Sorted by: Best Match Show Resources per page
Overview of Drug Transporters in Human Placenta.

International journal of molecular sciences

Yamashita M, Markert UR.
PMID: 34884954
Int J Mol Sci. 2021 Dec 05;22(23). doi: 10.3390/ijms222313149.

The transport of drugs across the placenta is a point of great importance in pharmacotherapy during pregnancy. However, the knowledge of drug transport in pregnancy is mostly based on experimental clinical data, and the underlying biological mechanisms are not...

Cite
Yamashita M, Markert UR. Overview of Drug Transporters in Human Placenta. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222313149.
Yamashita, M., & Markert, U. R. (2021). Overview of Drug Transporters in Human Placenta. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222313149
Yamashita, Michiko, and Markert, Udo R. "Overview of Drug Transporters in Human Placenta." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222313149
Yamashita M, Markert UR. Overview of Drug Transporters in Human Placenta. Int J Mol Sci. 2021 Dec 05;22(23). doi: 10.3390/ijms222313149. PMID: 34884954; PMCID: PMC8658420.
Copy Download .nbib Format: NLM
In Situ Exploration of Stimulus-Induced Emission Changes in Mechanochromic Dyes.

The journal of physical chemistry letters

Yamashita M, Nagai S, Ito S, Tachikawa T.
PMID: 34378940
J Phys Chem Lett. 2021 Aug 19;12(32):7826-7831. doi: 10.1021/acs.jpclett.1c02015. Epub 2021 Aug 11.

The development of in situ analysis techniques for visualizing and linking macro- and nanoscopic features of external stimulus-responsive materials is crucial for their rational design and applications. Herein, we investigate the mechanical stress-induced emission changes in electron donor-acceptor type...

Cite
Yamashita M, Nagai S, Ito S, et al. In Situ Exploration of Stimulus-Induced Emission Changes in Mechanochromic Dyes. J Phys Chem Lett. 2021;12(32):7826-7831doi: 10.1021/acs.jpclett.1c02015.
Yamashita, M., Nagai, S., Ito, S., & Tachikawa, T. (2021). In Situ Exploration of Stimulus-Induced Emission Changes in Mechanochromic Dyes. The journal of physical chemistry letters, 12(32), 7826-7831. https://doi.org/10.1021/acs.jpclett.1c02015
Yamashita, Maho, et al. "In Situ Exploration of Stimulus-Induced Emission Changes in Mechanochromic Dyes." The journal of physical chemistry letters vol. 12,32 (2021): 7826-7831. doi: https://doi.org/10.1021/acs.jpclett.1c02015
Yamashita M, Nagai S, Ito S, Tachikawa T. In Situ Exploration of Stimulus-Induced Emission Changes in Mechanochromic Dyes. J Phys Chem Lett. 2021 Aug 19;12(32):7826-7831. doi: 10.1021/acs.jpclett.1c02015. Epub 2021 Aug 11. PMID: 34378940.
Copy Download .nbib Format: NLM
Long-term risk of cancer development among anti-Th/To antibody-positive systemic sclerosis patients: comment on the article by Mecoli et al.

Arthritis & rheumatology (Hoboken, N.J.)

Yamashita Y, Yamano Y, Muro Y, Koizumi H, Takeichi T, Kondoh Y, Akiyama M.
PMID: 34351078
Arthritis Rheumatol. 2021 Aug 05; doi: 10.1002/art.41945. Epub 2021 Aug 05.

We read the report by Mecoli et al on the relationship between cancer and anti-Th/To antibodies (AThAs) in patients with systemic sclerosis (SSc) (1). It is interesting that the presence of AThAs was reported to confer a protective effect...

Cite
Yamashita Y, Yamano Y, Muro Y, et al. Long-term risk of cancer development among anti-Th/To antibody-positive systemic sclerosis patients: comment on the article by Mecoli et al. Arthritis Rheumatol. 2021;doi: 10.1002/art.41945.
Yamashita, Y., Yamano, Y., Muro, Y., Koizumi, H., Takeichi, T., Kondoh, Y., & Akiyama, M. (2021). Long-term risk of cancer development among anti-Th/To antibody-positive systemic sclerosis patients: comment on the article by Mecoli et al. Arthritis & rheumatology (Hoboken, N.J.), . https://doi.org/10.1002/art.41945
Yamashita, Yuta, et al. "Long-term risk of cancer development among anti-Th/To antibody-positive systemic sclerosis patients: comment on the article by Mecoli et al." Arthritis & rheumatology (Hoboken, N.J.) vol. (2021). doi: https://doi.org/10.1002/art.41945
Yamashita Y, Yamano Y, Muro Y, Koizumi H, Takeichi T, Kondoh Y, Akiyama M. Long-term risk of cancer development among anti-Th/To antibody-positive systemic sclerosis patients: comment on the article by Mecoli et al. Arthritis Rheumatol. 2021 Aug 05; doi: 10.1002/art.41945. Epub 2021 Aug 05. PMID: 34351078.
Copy Download .nbib Format: NLM
Acetabular Morphology in Patients with Developmental Dysplasia of the Hip with High Dislocation.

Hip & pelvis

Tateda K, Nagoya S, Suzuki D, Kosukegawa I, Yamashita T.
PMID: 33748023
Hip Pelvis. 2021 Mar;33(1):25-32. doi: 10.5371/hp.2021.33.1.25. Epub 2021 Mar 02.

PURPOSE: The current study aimed to investigate the morphology of the true acetabulum in developmental dysplasia of the hip (DDH) with high dislocation. A secondary was to evaluate the acetabular cup placement in patients with high dislocation who were...

Cite
Tateda K, Nagoya S, Suzuki D, et al. Acetabular Morphology in Patients with Developmental Dysplasia of the Hip with High Dislocation. Hip Pelvis. 2021;33(1):25-32doi: 10.5371/hp.2021.33.1.25.
Tateda, K., Nagoya, S., Suzuki, D., Kosukegawa, I., & Yamashita, T. (2021). Acetabular Morphology in Patients with Developmental Dysplasia of the Hip with High Dislocation. Hip & pelvis, 33(1), 25-32. https://doi.org/10.5371/hp.2021.33.1.25
Tateda, Kenji, et al. "Acetabular Morphology in Patients with Developmental Dysplasia of the Hip with High Dislocation." Hip & pelvis vol. 33,1 (2021): 25-32. doi: https://doi.org/10.5371/hp.2021.33.1.25
Tateda K, Nagoya S, Suzuki D, Kosukegawa I, Yamashita T. Acetabular Morphology in Patients with Developmental Dysplasia of the Hip with High Dislocation. Hip Pelvis. 2021 Mar;33(1):25-32. doi: 10.5371/hp.2021.33.1.25. Epub 2021 Mar 02. PMID: 33748023; PMCID: PMC7952268.
Copy Download .nbib Format: NLM
Reconstruction of the Midfoot Area with Vascularized Chimeric Osteocutaneous Scapula Flap: A Case Report.

Plastic and reconstructive surgery. Global open

Arata J, Tsuge I, Kumakiri M, Yamashita T, Kaito S, Yong Y, Yamada S.
PMID: 33747685
Plast Reconstr Surg Glob Open. 2021 Mar 15;9(3):e3361. doi: 10.1097/GOX.0000000000003361. eCollection 2021 Mar.

We report a case of reconstruction of a left midfoot defect with a chimeric partial scapula and skin flap in a 20-year-old man. After radical debridement, bone and soft tissue defects were reconstructed with a chimeric scapula and skin...

Cite
Arata J, Tsuge I, Kumakiri M, et al. Reconstruction of the Midfoot Area with Vascularized Chimeric Osteocutaneous Scapula Flap: A Case Report. Plast Reconstr Surg Glob Open. 2021;9(3):e3361doi: 10.1097/GOX.0000000000003361.
Arata, J., Tsuge, I., Kumakiri, M., Yamashita, T., Kaito, S., Yong, Y., & Yamada, S. (2021). Reconstruction of the Midfoot Area with Vascularized Chimeric Osteocutaneous Scapula Flap: A Case Report. Plastic and reconstructive surgery. Global open, 9(3), e3361. https://doi.org/10.1097/GOX.0000000000003361
Arata, Jun, et al. "Reconstruction of the Midfoot Area with Vascularized Chimeric Osteocutaneous Scapula Flap: A Case Report." Plastic and reconstructive surgery. Global open vol. 9,3 (2021): e3361. doi: https://doi.org/10.1097/GOX.0000000000003361
Arata J, Tsuge I, Kumakiri M, Yamashita T, Kaito S, Yong Y, Yamada S. Reconstruction of the Midfoot Area with Vascularized Chimeric Osteocutaneous Scapula Flap: A Case Report. Plast Reconstr Surg Glob Open. 2021 Mar 15;9(3):e3361. doi: 10.1097/GOX.0000000000003361. eCollection 2021 Mar. PMID: 33747685; PMCID: PMC7963493.
Copy Download .nbib Format: NLM
Enantioselective hydrophosphonylation of .

Organic & biomolecular chemistry

Chassillan L, Yamashita Y, Yoo WJ, Toffano M, Guillot R, Kobayashi S, Vo-Thanh G.
PMID: 34870670
Org Biomol Chem. 2021 Dec 15;19(48):10560-10564. doi: 10.1039/d1ob01953h.

The enantioselective hydrophosphonylation of

Cite
Chassillan L, Yamashita Y, Yoo WJ, et al. Enantioselective hydrophosphonylation of . Org Biomol Chem. 2021;19(48):10560-10564doi: 10.1039/d1ob01953h.
Chassillan, L., Yamashita, Y., Yoo, W. J., Toffano, M., Guillot, R., Kobayashi, S., & Vo-Thanh, G. (2021). Enantioselective hydrophosphonylation of . Organic & biomolecular chemistry, 19(48), 10560-10564. https://doi.org/10.1039/d1ob01953h
Chassillan, Louis, et al. "Enantioselective hydrophosphonylation of ." Organic & biomolecular chemistry vol. 19,48 (2021): 10560-10564. doi: https://doi.org/10.1039/d1ob01953h
Chassillan L, Yamashita Y, Yoo WJ, Toffano M, Guillot R, Kobayashi S, Vo-Thanh G. Enantioselective hydrophosphonylation of . Org Biomol Chem. 2021 Dec 15;19(48):10560-10564. doi: 10.1039/d1ob01953h. PMID: 34870670.
Copy Download .nbib Format: NLM
MUC1-C Dictates Neuroendocrine Lineage Specification in Pancreatic Ductal Adenocarcinomas.

Carcinogenesis

Luan Z, Morimoto Y, Fushimi A, Yamashita N, Suo W, Bhattacharya A, Hagiwara M, Jin C, Kufe D.
PMID: 34657147
Carcinogenesis. 2021 Oct 17; doi: 10.1093/carcin/bgab097. Epub 2021 Oct 17.

Pancreatic ductal adenocarcinomas (PDAC) and poorly differentiated pancreatic neuroendocrine (NE) carcinomas are KRAS mutant malignancies with a potential common cell of origin. PDAC ductal, but not NE, lineage traits have been associated with cell-intrinsic activation of interferon (IFN) pathways....

Cite
Luan Z, Morimoto Y, Fushimi A, et al. MUC1-C Dictates Neuroendocrine Lineage Specification in Pancreatic Ductal Adenocarcinomas. Carcinogenesis. 2021;doi: 10.1093/carcin/bgab097.
Luan, Z., Morimoto, Y., Fushimi, A., Yamashita, N., Suo, W., Bhattacharya, A., Hagiwara, M., Jin, C., & Kufe, D. (2021). MUC1-C Dictates Neuroendocrine Lineage Specification in Pancreatic Ductal Adenocarcinomas. Carcinogenesis, . https://doi.org/10.1093/carcin/bgab097
Luan, Zhou, et al. "MUC1-C Dictates Neuroendocrine Lineage Specification in Pancreatic Ductal Adenocarcinomas." Carcinogenesis vol. (2021). doi: https://doi.org/10.1093/carcin/bgab097
Luan Z, Morimoto Y, Fushimi A, Yamashita N, Suo W, Bhattacharya A, Hagiwara M, Jin C, Kufe D. MUC1-C Dictates Neuroendocrine Lineage Specification in Pancreatic Ductal Adenocarcinomas. Carcinogenesis. 2021 Oct 17; doi: 10.1093/carcin/bgab097. Epub 2021 Oct 17. PMID: 34657147.
Copy Download .nbib Format: NLM
Showing 4465 to 4471 of 4471 entries